Formats for Recording and Reporting. Annexure XV

Size: px
Start display at page:

Download "Formats for Recording and Reporting. Annexure XV"

Transcription

1 Formats for Recording and Reporting Annexure XV

2 1.0 Guidelines to fill up the Patient Card This card will be maintained at sub centre, where the PMW will enter dates of subsequent monthly doses collection by patient, till the last dose required and then discharge the patient on the due date of discharge and record accordingly. After every monthly doses supplied and achieving end status, the MPW will also ensure updating the Treatment Register at the PHC, on their next visit for any purpose Cell Information to be filled Registration No Running number for the fiscal year at PHC level starts as 001 on first day of the month of April Name Full name Address Full postal address and identification marks near the house to facilitate tracing of defaulter Duration of To be ascertained from case history to be written in months Disease Age In number of completed years PB & MB PB 1 to 5 patches and/or 1 nerve affected MB 6 and more patches and/or 2 more nerve affected Visible deformity Write Gr 1, for grade one disability, if there is only loss of sensation and Gr 2 for visible deformity New Case (Tick) A new case is defined as person with signs of leprosy who have never received treatment before Other Type Under NLEP all previously treated cases needing further treatment are recorded as other cases. It has been decided that all migrant cases from another state reporting at any state. Health Institution will also be grouped under this category. Specify the category like re-entry, transferred in, referred, change in classification or relapse. Date of first dose Write date as day/ month/ year of giving first blister pack of MDT, client swallows medicine in the presence of health worker/ pharmacist Date of Write date of collection of the subsequent dose as it will help in following the subsequent doses person who has not come to collect medicine. Do not tick. In case person has taken accompanied MDT write the date in the first cell and connect that cell with the other cells (number of cells corresponding to the number of extra blister packs taken) by a line with arrow mark in the end. Date of discharge Write date of completion of last blister pack as day/ month/ year discharge Refer to End Status Back of the card Write date of referral, place of referral and reason for referral Tick/ write RFT Released from treatment if person with PB leprosy has taken 6 blister packs in 9 months and that with MB leprosy 12 blister packs in 18 months. Tick Others: if person has not completed the treatment and write defaulter, died, migrated or unknown depending on the status. You may write the details for reference in subsequent visits After achieving the End Status, the MPW should put her/his signature on the patient card and retain the same at sub centre for future reference. In urban situation also the same card is to be used. However appropriate Health unit, Area and Region may be indicated in the place of sub centre /PHC/Block lxxiv

3 L.F. 01 NATIONAL LEPROSY ERADICATION PROGRAMME (NELP) PATIENT CARD Sub centre PHC Block/CHC Districts State Registration Number: SC ST Others Name Age Female Male Address Duration of the disease Classification PB MB New Case Visible Deformity Yes No Remarks Date of First Dose AFTER ENTERING ABOVE INFORMATION IN THE PHC TREATMENT RECORD, THIS PATIENT CARD IS TO BE TRANSFERRED TO SUB CENTER FOR DELIVERY OF SUBSEQUENT DOSES Other Type (Specify) Signature of Medical Officer Date of subsequent doses: PB (Final) Date of discharge End Status RFT Others (specify) THIS CARD IS TO BE MAINTAINED AT SUB CENRE. AFTER EVERY DOSE, UPDATE THE PHC TREATMENT RECORD. AFTER ACHIEVING END STATUS, THEMPW SHOULD SIGN THISCARD AND RETAIN AT SUB Registration Number Classification CENTRE FOR FUTURE REFERENE Guidelines to fill-up this card Running number for the fiscal year at PHC level PB- 1 to 5 patches and/or 1 nerve affected MB 6 and more patches and/or 2 or more nerve affected Signature of Sub centre MPW New Case Other Type End Status A leprosy patient who has not taken MDT drugs anywhere earlier Includes Immigrant, Relapse, Referral or Restart of treatment RFT Released From Treatment OTHERS DEFAULTER (Case of PB or MB consecutively absent for a period of 12 months from the last dose)/died/migrated/unknown *In Urban situation, this same card I to be used. However, appropriate Health Unit, Area and Region may be Indicated in the place of Sub center/phc/block lxxv

4 Note: Categorization of other cases (recorded for PB and MB) (a) Relapse Relapse is defined as the re-occurrence of the disease at any time after the completion of a full course of treatment. Diagnosis must be evidence based and must be diagnosed after adequate screening. (b) Reentered for treatment - These are previously treated cases, where clinical assessment shows requirement of further treatment and patient admits that treatment was not completed. (c) Referred cases patient referred for completion of treatment (remaining doses) by tertiary or second level institutions after diagnosis and issue of first dose, or from another Health centre on patients request or migratory patient from another District/State. All referred cases should have a referral slip showing diagnosis and remaining doses to be given. (d) Change in classification persons with PB leprosy; reclassified to MB and need full course of MB treatment. (e) Cases from outside the state & Temporary migration or cross border cases. This information will be recorded in a separate register (LF-02/A) and reported separately in the monthly progress reports. Before deciding a case to be recorded as from other state, the residential status at the place of diagnosis be carefully examined. A person who is residing for more than six month and is likely to stay till completion of treatment, be recorded as indigenous case and will not be categorized under other cases. 2.0 Treatment Record The Treatment Record (L.F. 02) should be kept in a Register in all Primary Health Centers/Block PHC/CHC wherever leprosy cases are diagnosed and treated. As discussed earlier, at first the patient card is prepared by the Medical Officer diagnosing the case of leprosy. The information will thereafter be filled up in the Treatment Record. The Annual Serial Registration Number will also be available from this Register. The Medical Officer I/C of PHC/CHC etc. can give this responsibility to one of the General Health Care Staff working in the Health Centre. The information entered should be exactly similar to the one recorded in the patient card. The person(s) entrusted with responsibility of filling up the Treatment Record, should also ensure updating of the records of all patients being treated at sub centers on receipt of factual information from the concerned MPW(s). Any default on receipt of information should be promptly brought to the notice of the Medical Officer in-charge who will ensure updating of the record. The same L.F. 02 form is also to be used in all Hospitals, NGO institutions engaged in diagnosing and treating leprosy cases. The Name of PHC/Block PHC/CHC should be replaced by Name of Hospital/NGO Institution. The Registration Number will be changed every year starting from 001 on 1 st April of the Fiscal year (say 1 st April 2002 to 31 st March 2003). The treatment record will be retained in the Health Centre/Hospital/NGO institutions for future reference. lxxvi

5 LF - 02 NATIONAL LEPROSY ERADICATION PROGRAMME (NLEP) PHC TREATMENT RECORD PHC Block PHC/ CHC DISTRICT Reg Sub No. Centre State Fiscal Year Name Address Age Sex SC/ PB/ M/F ST MB Date of Subsequent Doses New/ Others Visible Defor. Y/N Date of first dose PB (final) Date of RFT Remarks lxxvii

6 LF -02/A Register for Recording " other cases " Name of PHC- District- State- S. No. Age Sex Complete address to which the patient belongs (must record village/block/distt/state) Diagnosis (PB/MB) Relapse Partial treated old cases Rentered for treatment Type of case Referred cases Change in classification to PB/MB Patient belong to State/UT of lxxviii

7 LF-02/A Contd. Register for Recording " other cases " Treatment record with date Disablity status Gr.I/Gr.II Date of RFT Remarks lxxix

8 3. Leprosy MDT Drug Stock Record The MDT Drug Stock Record (L.F. 03) is to be maintained in all PHC/Block PHC/CHC where MDT is supplied from the district and stocked. This is to be maintained in a Register. Separate pages should be used for each of the 4 types of MDT Blister Packs supplied viz. MB (Adult), MB (Child), PB (Adult), PB (Child). Guidelines to fill up the form Transaction Date Quantity received/issued Date on which the drug is received or issued (Expenditure). Number of Blister Calendar Packs (BCP) received or issued From where Source of receipt say DLO Ghaziabad or Block PHC Madhubani Vide Reference No. Batch No. Expiry Date To whom Balance in hand Remarks No. & date of order under which the drug has been supplied/ issued. As recorded in the BCP cover/ packing box As recorded in the BCP cover/ packing box Indicate to whom issued say Mornoi sub centre Enter quantity as should be available as per Record. (Must enter on each transaction date) Record any receipt in damaged condition, shortage in receipt against Ref. No., discoloration appearing at any time etc. giving quantity and indicating action taken. Similar form (L.F. 03) is to be used at District and State level drug stores also. Hospitals in urban situations and NGO Institutions should also keep similar records. Drug stock records are important document and should not be changed annually. Same Register can be used for number of years. The record will be retained in the Health centre/hospital/ngo Institute/District/State for future reference and audit. lxxx

9 Annexure III L.F. 03 NLEP LEPROSY MDT DRUG STOCK RECORD Use separate page for each category of MDT [MB(A)/ MB(C)/ PB(A)/ PB(C)] Specify category : (Same format to be used at PHC/District/State levels Please specify level with name along with next highest level up to State) PHC Block PHC/ CHC District State Fiscal Year Transaction Date Quantity. Received From Where Receipt Vide Ref. No. Batch No. Expiry Date Quantity Issued Vide Ref. No Expenditure To whom Batch No. Expiry date Balance In Hand Remarks lxxxi

10 4. Reports The data recorded in various centers need to be periodically collected and put in a pre designed format for sending to the next higher level for further use. These are called the reporting formats. The Simplified Information System under NLEP has accepted the following two reporting formats ML.F. 04 NLEP monthly reporting form PHC/Block PHC report 4.1 NLEP Monthly reporting form - PHC The ML.F. 04 form will be utilized by the Primary Health Centre, which is the basic recording unit under NLEP. This simple form will be filed up from the data available in the Treatment record and the Drug Stock record maintained at the PHC Guideline for filling the form Put name of PHC/Block PHC/District/State/reporting month and Fiscal year at the top. S.No. 1 No. of cases at the beginning of the reporting month i.e. S.No. 5 of previous month s report S.No. 2 Total New Leprosy cases detected in the reporting month (Adult & child) Put PB and MB cases in space provided in 1 st column and put total in white space provided in right hand column. S.No. 3 Among the new leprosy cases detected, number of Put specific number in the 1 st column provided. S.No. 4 Number of cases deleted in the reporting month RFT Number, released from treatment after completion of all doses of MDT. Others Deleted from record due to Death/ Migration/ absent for more than 3 months (PB) / six months (MB) / unknown reason. Put total in the blank space given in right hand column. S.No. 5 Number of cases at the end of the reporting month Put figure arrived at by adding total in S.No. 1 and S. No. 2 and then subtracting total in S.No. 4. S.No. 6 No: of other cases recorded and put under treatment. Relapse, re-entry, transferred in, referred, change in classification or migrated from other states. S.No. 7 Number of other cases deleted due to completion of treatment or due to other reasons like migration/ transfer out/ death etc. S. No. 8 Total number of other cases; PB, MB & Total; under treatment (6-7) S. No. 9 Leprosy drug stock at the end of the reporting month Put balance quantity of each drug a per record on the last date of transaction, Specify expiry date along with the quantity with that expiry date, calculate no; of BCPs available for each patient under treatment. Remarks: Any important information to be included regarding drug shortage. The report is to be signed by the Medical Officer In-charge of the PHC. The same form should be used by Hospitals/NGO Institutions also lxxxii

11 NLEP Monthly Reporting Form PHC / Block PHC Report M.L.F. 04/ A [ Page 1] PHC District Reporting Month Block State Year 1. No. of balance new cases at the beginning of the month PB TOTAL 2. No.of New Leprosy Cases detected in the reporting month During reporting month 3. Among new leprosy cases detected during the reporting month, number of Adult Child Total Female Deformity 4. Number of New leprosy cases deleted during the month RFT - Otherwise deleted 6. 5 Number of New leprosy cases under treatment at the end of the month (1+2-4) 7 8 Number of "other cases" recorded and put under treatment No. of 'other cases' deleted from treatment No. of other cases under treatment at the end of reporting month SC ST Total (i) Relapsed MB Grade-I Grade-II (ii) Reentered for treatment (iii) Referred (iv) Reclassified (v) From other states Total RFT Otherwise deleted Total PB MB TOTAL 9 Leprosy Drug Stock at the end of the reporting month (if required use extra sheets) : Blister Pack Quantity Expiry Date Total stock No. of patients under treatment Patient monthbcp MB (C) PB (C) lxxxiii

12 MLF 04/A [Page 2] S.NO. DPMR activities During reporting month PB MB Total 1 No. of reaction cases recorded 2 No.of reaction cases managed at PHC 3 No.of reaction cases referred to Dist. Hosp. /other instt. 4 No. of suspected relapse cases and referred by PHCs 5 No. of relapse confirmed at District Hospital 5 No. of cases developed new disability after MDT 6 No. of patients provided with footwear 7 No. of patients provided with self care kit 8 No. of patients referred for RCS at tertiary instt. 9 No. of instt, providing RCS 10 No. of cases referred for skin smear 11 No. found +ve for AFB Date : Name and Signature of the Medical Officer lxxxiv

13 Anaesthesia palm Claw hand Ulcer Absorption of finger Any other disability Anaesthesia sole Foot drop Ulcer Foot Absorption of toes Other disabilities (Foot) Lagophthalmos Low Vision Red Eye Disability Register PHC / primary care unit District State Form P I 1 S.No Name of the patient Age/ Sex Postal address Date of Registration Type of leprosy Treatment (MDT) status (No. of BCP taken) Column No Disability Grade 2 Hands Feet Eye Services provided with date Change / progress noticed Referred to with date Column No Date Services Date Changes lxxxv

14 5.0 How to fill up the Form P-I Column 1: Serial no. to disabled cases is to be given Column 2: Complete name with surname along with son / daughter / wife of should be written Column 3: If patient is unable to tell the age, age should be assessed Column 4: Complete postal address with landmark / PIN to be given Column 5: Date of registration for MDT is to be written Column 6: PB or MB is to be written Column 7: Total number of BCP, MDT should be written Column 9 to 21: Tick mark on disability detected, more than 1 disability may be there. Column 22-23: Services such as self care training, ulcer care, surgery, issuing MCR shoes, refer to secondary level etc. may be entered along with respective dates. Column 24-25: Changes like ulcer healed, ulcer recurred, contractual developed, vision deteriorated new nerve damaged noticed etc. lxxxvi

15 Form P III Record of Lepra Reaction/ Neuritis (LRN) cases PHC/ district No.1 S. No. No.2 No.3 No.4 No.5 Name of the patient Date of MDT No. / registration Type of leprosy registration No. MB PB Type I No.6 Lepra Reaction Neuritis II Y N No.7 Treatment given Prednisolone doses issued with dates No.8 Other drugs No.9 New disability developed After start of prednisolone Yes No No.10 Remarks How to fill up the Form I Column 1: Serial no. of reaction cases is to be given Column 2: Complete name with surname along with son / daughter / wife of should be written Column 3: Date of registration of MDT is to be written Column 7: Doses of Prednisolone in milligram with date of issue to be filled Column 8: Enter Clofazimine, Analgesics, Mebandazole, or any other drug given. Column 9: In case of yes, write the nature and site(lt /RT) of disability developed lxxxvii

16 Form P II Disability Assessment form Assessment of Disability & Nerve Function Name Village Dt. of Regn S/o, W/o, D/o Sub Centre Dt. of RFT Gender/Age MDT No. Referred by Occupation MB/PB Date of assessment On date RIGHT Max. (WHO) Disability Grade EHF score Signature of Assessor Date Vision (0,1,2) Light Closure lid gap in mm. Blink Present / Absent Little Finger Out Thumb Up Wrist Extension Foot Up Disability Grade Hands Disability Grade Feet Disability Grade Eyes LEFT Muscle power: S = Strong W = Weak P = Paralysis Score of vision: counting fingers at 6 meters 0 = Normal 1= Blurring vision 2 = Unable to count fingers This form should be filled-in at the time of registration and repeated after 3 months (once in 2 weeks in case of neuritis/reaction) lxxxviii

17 SENSORY ASSESSMENT DATE / ASSESSOR Palm Sole Comments RIGHT LEFT RIGHT LEFT Key : (Put these mark/icon on the site where lesion is seen) Sensation Present within 3 cms Contracture Anaesthesia Wound Clawing Crack Scar/Callus Shortening Level lxxxix

18 Form P III Record of Lepra Reaction/ Neuritis (LRN) cases PHC/ district No.1 S. No. No.2 No.3 No.4 No.5 Name of the patient Date of MDT No. / registration Type of leprosy registration No. MB PB Type I No.6 Lepra Reaction Neuritis II Y N No.7 Treatment given Prednisolone doses issued with dates No.8 Other drugs No.9 New disability developed After start of prednisolone Yes No No.10 Remarks How to fill up the Form I Column 1: Serial no. of reaction cases is to be given Column 2: Complete name with surname along with son / daughter / wife of should be written Column 3: Date of registration of MDT is to be written Column 7: Doses of Prednisolone in milligram with date of issue to be filled Column 8: Enter Clofazimine, Analgesics, Mebendazole, or any other drug given. Column 9: In case of yes, write the nature and site (LT /RT) of disability developed xc

19 Form P IV Prednisolone Card (This card should be kept with the patient) INSTRUCTIONS TAKE PREDNISOLONE TABLETS AS SINGLE DOSE DAILY WITH MILK / FOOD BUT NEVER ON EMPTY STOMACH RESTRICT SALT INTAKE TILL ON PREDNISOLONE INFORM SOON IF YOU NOTICE BLACK STOOL (MALENA), PAIN UPPER ABDOMEN OR VOMITING NATIONAL LEPROSY ERADICATION PROGRAMME PREDNISOLONE CARD Name of the patient.. Reg. No./ MDT No. INFORM IMMEDIATELY IF DISCHARGE IN PLANTER ULCER, ANY FOCUS OF INFECTION, PERSISTING COUGH, MILD FEVER OR ANY DETERIORATION DON T STOP PREDNISOLONE BEFORE COMPLETION OF REGIMEN, EVEN IF THERE IS IMPROVEMENT OR DETERIORATION. REPORT FOR REVIEW / CHECKUP AND NEXT DOSAGE, EVERY FORTNIGHT Type MB / PB Date / Due Date of RFT. Indication for Prednisolone therapy: Date of starting Prednisolone... PREDNISOLONE RECORD Other drugs issued.. Dosage Date of issue Next due date Signature 40mg x 2 wk. 30mg x 2 wk. 20mg x 2 wk. Do (if required)... Progress / Remarks 15mg x 2 wk. 10mg x 2 wk. 5mg x 2 wk. Signature of MO.. Name. xci

20 Referral Register PHC district State S.No. Name of the person Age and Sex Address Reason / indication for referring Referred to Date of referral Referral services provided Follow-up actions taken with date Form P V Date action xcii

21 Form P VI Referral Slip (to be used by peripheral health worker) PHC District State Name of the person to be referred: Age and Sex : Address : Clinical finding : Reason / indication : for referring Referred to: Referred by (designation & place) : Signature & date : xciii

22 Referral Slip (to be used by MO PHC) Form P VII PHC District State Name of the person to be referred: Age and Sex : Address : Clinical finding : Reason / indication : for referring Referred to: Copy marked to District Nucleus on: Action taken at referral centers : instructions for follow up: Referred by (designation & place) : Signature & date : xciv

23 Anaesthesia palm Claw hand Ulcer Absorption of finger Any other disability Anaesthesia sole Foot drop Ulcer Foot Absorption of toes Other disabilities (Foot) Lagophthalmos Low Vision Red Eye Profile of disabled leprosy cases of PHC Form - P.VIII PHC District State Date of Report S.No. Total no. of leprosy cases on record No. of leprosy cases assessed for disability No. of cases with disability Gr I Gr II Total Column No No. of cases disability wise Hands Feet Eye Action (management) taken / to be taken Column No xcv

Guidelines for Performance based Payment for ASHA under National Leprosy Eradication Programme

Guidelines for Performance based Payment for ASHA under National Leprosy Eradication Programme Guidelines for Performance based Payment for ASHA under National Leprosy Eradication Programme Introduction: Under Health System, Multi-purpose Workers (MPW- Male & Female) at the sub- centre act as the

More information

HOW TO MONITOR LEPROSY ELIMINATION IN YOUR WORKING AREA. World Health Organization

HOW TO MONITOR LEPROSY ELIMINATION IN YOUR WORKING AREA. World Health Organization HOW TO MONITOR LEPROSY ELIMINATION IN YOUR WORKING AREA World Health Organization HOW TO MONITOR LEPROSY ELIMINATION IN YOUR WORKING AREA contents The Final Push to Eliminate Leprosy 2 Why do we monitor?

More information

Rajbir Singh German Leprosy and TB Relief Association

Rajbir Singh German Leprosy and TB Relief Association A Study to assess the reasons for delayed presentation among newly detected adult leprosy patients with disability and develop appropriate recommendations to reduce the delay in endemic districts of Delhi,

More information

Regional Strategy for Sustaining Leprosy Services and Further Reducing the Burden of Leprosy

Regional Strategy for Sustaining Leprosy Services and Further Reducing the Burden of Leprosy SEA-LEP-162 Distribution: General Regional Strategy for Sustaining Leprosy Services and Further Reducing the Burden of Leprosy - 2006-2010 WHO Project: ICP CPC 600 World Health Organization, August 2005

More information

Management information system for leprosy eradication programme---an alternative information system *

Management information system for leprosy eradication programme---an alternative information system * Lepr Rev (1989) 60, 129-134 Management information system for leprosy eradication programme---an alternative information system * C R REV ANKAR, NIVEDIT A GOYAL & BIRTE H SORENSEN DANIDA Assisted NLEP-MDT

More information

NGO Schemes in National Leprosy Eradication Programme (NLEP)-2013

NGO Schemes in National Leprosy Eradication Programme (NLEP)-2013 NGO Schemes in National Leprosy Eradication Programme (NLEP)-2013 CENTRAL LEPROSY DIVISION DIRECTORATE GENERAL OF HEALTH SERVICES MINISTRY OF HEALTH & FAMILY WELFARE NIRMAN BHAWAN, NEW DELHI-110011 Govt.

More information

APPLICATION PACK BURJ DAYCARE NURSERY

APPLICATION PACK BURJ DAYCARE NURSERY APPLICATION PACK BURJ DAYCARE NURSERY Child s Name: This application form must be fully completed and the necessary documents provided before a child can start at nursery. Child s Details Child s name:

More information

Community DVT Service. Phase 3: Anticoagulation at DVT Treatment Centres

Community DVT Service. Phase 3: Anticoagulation at DVT Treatment Centres Community DVT Service Quick Reference Guide Phase - Anticoagulation Phase : Anticoagulation at DVT Treatment Centres If a Patient has had a positive Ultrasound Scan they attend one of the DVT Treatment

More information

- Primary 1,208 - Junior High School High School Intermediate Graduate 14 - Post Graduate 03 No. of Urban Slums 227

- Primary 1,208 - Junior High School High School Intermediate Graduate 14 - Post Graduate 03 No. of Urban Slums 227 DISTRICT PROFILE - VARANASI (2009) Introduction district is the place where Lord Buddha delivered his first sermon. city, also known as Benares is one of the seven sacred cities of Hindus. The city is

More information

Educational Posters and Leaflets on Leprosy: Raising Awareness of Leprosy for Health-Care Workers in Rural South Africa

Educational Posters and Leaflets on Leprosy: Raising Awareness of Leprosy for Health-Care Workers in Rural South Africa Special Section on Leprosy Educational Posters and Leaflets on Leprosy: Raising Awareness of Leprosy for Health-Care Workers in Rural South Africa Idongesit Sunday Ukpe, MBBCh, DTM&H, MMed, FACTM a SYNOPSIS

More information

Community Health Services in Bristol Community Learning Disabilities Team

Community Health Services in Bristol Community Learning Disabilities Team Community Health Services in Bristol 2014 Community Learning Disabilities Team This provides specialist community based services for adults with learning difficulties and help to promote equal access to

More information

Cobimetinib (Cotellic ) ( koe-bi-me-ti-nib )

Cobimetinib (Cotellic ) ( koe-bi-me-ti-nib ) Cobimetinib (Cotellic ) ( koe-bi-me-ti-nib ) How drug is given: by mouth Purpose: to stop the growth of melanoma cancer cells How to take this drug 1. This drug can be taken with or without food. 2. Swallow

More information

Table 1. State-Wise Area, Districts and Villages in India 14. State-Wise Rural and Urban Population as per 1991 and 2001 Census

Table 1. State-Wise Area, Districts and Villages in India 14. State-Wise Rural and Urban Population as per 1991 and 2001 Census CONTENTS Page Part 1. Rural Health Care System in India 1 Part 2. Detailed Statistics Chapter I. Demographic Indicators Table 1. State-Wise Area, Districts and Villages in India 14 Table 2. State-Wise

More information

Part 1. Rural Health Care System in India 1. Table 1. State-Wise Area, Districts and Villages in India 28

Part 1. Rural Health Care System in India 1. Table 1. State-Wise Area, Districts and Villages in India 28 CONTENTS Page List of Abbreviations Highlights ii vii-x Part 1. Rural Health Care System in India 1 Part 2. Detailed Statistics Section I. Demographic Indicators Table 1. State-Wise Area, Districts and

More information

Procedure For Taking Walk In Patients

Procedure For Taking Walk In Patients Procedure For Taking Walk In Patients 1. Welcome customers and accept prescription(s) from them. All Staff 2. Ensure that the patients personal details are correct and legible To ensure correct details

More information

ARE WE MISSING RELAPSES IN LEPROSY?

ARE WE MISSING RELAPSES IN LEPROSY? Vol. 14 - No. 2 FOR PRIVATE CIRCULATION ONLY APRIL 2006 ARE WE MISSING RELAPSES IN LEPROSY? Multi Drug Therapy (MDT) is believed to be one of the most robust regimens ever introduced for the treatment

More information

One year follow up of acohort of suspected leprosy cases: findings from a Leprosy Selective Special Drive in Gadchiroli District, Maharashtra, India

One year follow up of acohort of suspected leprosy cases: findings from a Leprosy Selective Special Drive in Gadchiroli District, Maharashtra, India Lepr Rev (2012) 83, 64 70 One year follow up of acohort of suspected leprosy cases: findings from a Leprosy Selective Special Drive in Gadchiroli District, Maharashtra, India VANAJAP.SHETTY &SHUBHADA S.

More information

Patient satisfaction in national leprosy eradication programme Mohite RV 1, Mohite VR 2, Durgawale PM 3

Patient satisfaction in national leprosy eradication programme Mohite RV 1, Mohite VR 2, Durgawale PM 3 Bangladesh Journal of Medical Science Vol. 12 No. 03 July 13 Original article: Patient satisfaction in national leprosy eradication programme Mohite RV 1, Mohite VR 2, Durgawale PM 3 Abstract: Background:

More information

Sentinel node biopsy. Patient Information to be retained by patient

Sentinel node biopsy. Patient Information to be retained by patient PLEASE PRINT WHOLE FORM DOUBLE SIDED ON YELLOW PAPER Patient Information to be retained by patient affix patient label Sentinel Node Biopsy What is a sentinel node biopsy? The lymphatic drainage from your

More information

North West Residential Support Services Inc. Policies & Procedures PROCEDURES FOR THE ADMINISTRATION OF MEDICATION IN SHARED HOMES

North West Residential Support Services Inc. Policies & Procedures PROCEDURES FOR THE ADMINISTRATION OF MEDICATION IN SHARED HOMES North West Residential Support Services Inc. Policies & Procedures PROCEDURES FOR THE ADMINISTRATION OF MEDICATION IN SHARED HOMES Number: Effective From: Replaces: Review: NWRSS

More information

Best Practice Guidance for GP Practices, Community Pharmacists and Care Home Providers

Best Practice Guidance for GP Practices, Community Pharmacists and Care Home Providers Medicines Management in Care Homes Best Practice Guidance for GP Practices, Community Pharmacists and Care Home Providers 1. Communication The care home manager, community pharmacist and GP surgery should

More information

Application of eye drops

Application of eye drops Work Health Safety: : Personal & Medical Application of drops Risks Risk Level Risk Controls Infection of people from clients blood and other fluids Infection of client from open wound Client/staff emotional

More information

PRE-ASSESSMENT GUIDELINES AND FORMS FOR PHC/CHC

PRE-ASSESSMENT GUIDELINES AND FORMS FOR PHC/CHC NABH-PHC/CHC-PA PRE-ASSESSMENT GUIDELINES AND FORMS FOR PHC/CHC Issue No. 2 Issue Date: 06/12 Page 1 of 9 CONTENTS Sl. Title Page Nos. Content 2 1. Guide to use Pre-Assessment Forms & Checklist 3 5 2.

More information

MULTI-AGENCY REFERRAL FORM

MULTI-AGENCY REFERRAL FORM MULTI-AGENCY REFERRAL FORM For referral of patients who have difficulty managing their prescribed medication. Complete the form and forward it to the patient s community pharmacist Patient name: Telephone:

More information

PREPARATION AND ADMINISTRATION

PREPARATION AND ADMINISTRATION LESSON PLAN: 12 COURSE TITLE: UNIT: IV MEDICATION TECHNICIAN PREPARATION AND ADMINISTRATION SCOPE OF UNIT: Guidelines and procedures for preparation, administration, reporting, and recording of oral, ophthalmic,

More information

Expiry Date: January 2009 Template Version: Page 1 of 7

Expiry Date: January 2009 Template Version: Page 1 of 7 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT Clinical Condition Indication: Inclusion criteria: Exclusion criteria: Cautions/Need for

More information

Hector Naidoo and Associates Future Leaders Bursary BURSARY APPLICATION FORM

Hector Naidoo and Associates Future Leaders Bursary BURSARY APPLICATION FORM Hector Naidoo and Associates Future Leaders Bursary BURSARY APPLICATION FORM SECTION 1 Dear applicant, We have pleasure enclosing an application form. When completing the form, please take note of the

More information

WORKPLACE HEALTH AND SAFETY & FIRST AID POLICY

WORKPLACE HEALTH AND SAFETY & FIRST AID POLICY WORKPLACE HEALTH AND SAFETY & FIRST AID POLICY Introduction The ACT Jewish Community (ACTJC) is committed to providing a safe and healthy environment for employees; volunteers; contractors, and visitors.

More information

Programme Implementation Plan (PIP) for 12 th Plan Period ( to )

Programme Implementation Plan (PIP) for 12 th Plan Period ( to ) Programme Implementation Plan (PIP) for 12 th Plan Period (2012-13 to 2016-17) CENTRAL LEPROSY DIVISON Directorate General of Health Services Ministry of Health & Family Welfare Govt. of India 1 NATIONAL

More information

Managing medicines in care homes

Managing medicines in care homes Managing medicines in care homes http://www.nice.org.uk/guidance/sc/sc1.jsp Published: 14 March 2014 Contents What is this guideline about and who is it for?... 5 Purpose of this guideline... 5 Audience

More information

Incident, Accident and Near Miss Procedure

Incident, Accident and Near Miss Procedure Incident, Accident and Near Miss Procedure Ref: ELCCG_HS03 Version: Version 2 Supersedes: Version 1 Author (inc Job Title): Ratified by: (Name of responsible Committee) Date ratified: 13/04/16 Review date:

More information

Patient Group Direction for Aspirin 300mg Version: 02 Start Date: 1 st October 2017 Expiry Date: 30 th September 2019

Patient Group Direction for Aspirin 300mg Version: 02 Start Date: 1 st October 2017 Expiry Date: 30 th September 2019 THIS PATIENT GROUP DIRECTION HAS BEEN AGREED BY THE FOLLOWING ORGANISATIONS: CLINICAL COMMISSIONING GROUP: Doncaster CCG, Lancashire CCGs including East Lancashire, Fylde and Wyre and North Lancashire

More information

Patient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM DOCETAXEL + PREDNISOLONE. Patient s first names

Patient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM DOCETAXEL + PREDNISOLONE. Patient s first names Patient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM DOCETAXEL + PREDNISOLONE Patient s surname/family name Patient s first names Date of birth Hospital Name: Guy s

More information

University of Miami Clinical Enterprise Technologies

University of Miami Clinical Enterprise Technologies Provider Manual 1 Our Mission: To design and deliver ongoing support for a network of Business and Clinical Information Management Systems which enhance the academic and research vision while implementing

More information

WHO/HTM/TB/ Task analysis. The basis for development of training in management of tuberculosis

WHO/HTM/TB/ Task analysis. The basis for development of training in management of tuberculosis WHO/HTM/TB/2005.354 Task analysis The basis for development of training in management of tuberculosis This document has been prepared in conjunction with the WHO training courses titled Management of tuberculosis:

More information

Last Name First Middle. Mailing Address. City State Zip Phone. Date of Birth Age Soc. Sec# Cell. Employer Work Phone

Last Name First Middle. Mailing Address. City State Zip Phone. Date of Birth Age Soc. Sec# Cell. Employer Work Phone Last Name First Middle Mailing Address City State Zip Phone Date of Birth Age Soc. Sec# Cell Employer Work Phone Email Address Emergency contact Phone # Relation: Name of Primary Insurance Policy # -----

More information

Medicines Reconciliation Standard Operating Procedures

Medicines Reconciliation Standard Operating Procedures Creator Sam Carvell, Amber Wynne, Sue Coppack Version 1 Review Date Medicines Reconciliation Standard Operating Procedures Purpose of SOP This standard operating procedure (SOP) provides a framework for

More information

Persons Affected with Leprosy Homes 4 No. of PAL living in these homes 135

Persons Affected with Leprosy Homes 4 No. of PAL living in these homes 135 DISTRICT PROFILE NAINITAL (2008) Introduction Nainital, the 'Lake District' of India is a valley having a pear-shaped lake of two miles in circumference, and surrounded by mountains like Naina (2,615 m),

More information

MEDICINES RECONCILIATION GUIDELINE Document Reference

MEDICINES RECONCILIATION GUIDELINE Document Reference MEDICINES RECONCILIATION GUIDELINE Document Reference G358 Version Number 1.01 Author/Lead Job Title Jackie Stark Principle Pharmacist Clinical Services Date last reviewed, (this version) 29 November 2012

More information

Country experience on engaging large hospitals - INDIA

Country experience on engaging large hospitals - INDIA Ninth Meeting of the Sub- group on PPM for TB Care and Control and Global Workshop on Engaging Large Hospitals, 28-30 August 2013 Country experience on engaging large hospitals - INDIA Sreenivas A Nair

More information

Federal Ministry of Health

Federal Ministry of Health Federal Ministry of Health MDR TB Follow up Register INSTRUCTION FOR MDR TB REGISTRATION AT TREATMENT FOLLOW UP HEALTH FACILITIES SN Variable Description 1 MDR TB reg. Number Write a new unique patient

More information

Madurai Health and Leprosy Relief Centre

Madurai Health and Leprosy Relief Centre Madurai Health and Leprosy Relief Centre MAHELERECEN Brief Report of Mahelerecen and Annual Report (2011-2012) 12/10, Sister Rose 2nd Street, Melaponnagaram, Madurai - 625 016, Tamil Nadu, South India

More information

Etoposide (VePesid ) ( e-toe-poe-side )

Etoposide (VePesid ) ( e-toe-poe-side ) Etoposide (VePesid ) ( e-toe-poe-side ) How drug is given: by mouth Purpose: to stop the growth of cancer cells in ovarian cancer, small cell lung cancer, Hodgkin disease, and other cancers How to take

More information

Facilitative Counselling for better patient management in leprosy

Facilitative Counselling for better patient management in leprosy Facilitative Counselling for better patient management in leprosy A sick person needs more than medicament. She/he needs to be told about the disease, its cause and consequence, the treatment and the expected

More information

Patient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM CYTARABINE CONTINUOUS INFUSION

Patient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM CYTARABINE CONTINUOUS INFUSION Patient identifier/label: Page 1 of 6 CYTARABINE Patient s surname/family name Patient s first names Date of birth Hospital Name: Guy s Hospital St. Thomas Hospital King s College Hospital Lewisham Hospital

More information

Paragon Infusion Centers Patient Information

Paragon Infusion Centers Patient Information Paragon Infusion Centers Patient Information Please complete the following form as accurately as you are able. Inaccurate and/or incomplete information can delay our ability to authorize your treatments,

More information

PATIENT INFORMATION. Address: Sex: City: State: address: Cell Phone: Home Phone: Work Phone: address: Cell Phone:

PATIENT INFORMATION. Address: Sex: City: State:  address: Cell Phone: Home Phone: Work Phone:  address: Cell Phone: PATIENT INFORMATION Name: _ DOB: _ Age: Address: _Sex: City: _ State: _ Zip: _ Email address: Cell Phone: _ Home Phone: Work Phone: _ Responsible Party (if different from above) Name: DOB: Address: E-mail:

More information

Patient Identifiers: Facial Recognition Patient Address DOB (month/day year) / / UHHC. Month Day Year / / Month Day Year

Patient Identifiers: Facial Recognition Patient Address DOB (month/day year) / / UHHC. Month Day Year / / Month Day Year Transfer (M0010) CMS Certification Number: 367549 (M0014) Branch State: OH (M0016) Branch ID Number: N/A Patient Identifiers: Facial Recognition Patient Address DOB (month/day year) / / UHHC (M0020) Patient

More information

Manchester Royal Eye Hospital. Welcome to the Acute Ophthalmic Services at Manchester Royal Eye Hospital

Manchester Royal Eye Hospital. Welcome to the Acute Ophthalmic Services at Manchester Royal Eye Hospital Manchester Royal Eye Hospital Welcome to the Acute Ophthalmic Services at Manchester Royal Eye Hospital The Acute Ophthalmic Services at Manchester Royal Eye Hospital consists of the Emergency Eye Centre

More information

I. PROFORMA FOR PROGRESS REPORT

I. PROFORMA FOR PROGRESS REPORT PART 3. ANNEXURES I. PROFORMA FOR PROGRESS REPORT PROFORMAE FOR REPORT ON RURAL HEALTH STATISTICS (As on 31 st March, 2017) 141 GENERAL INSTRUCTION FOR FILLING THE PROFORMA 1. Please read all columns carefully

More information

Social care guideline Published: 14 March 2014 nice.org.uk/guidance/sc1

Social care guideline Published: 14 March 2014 nice.org.uk/guidance/sc1 Managing medicines in care homes Social care guideline Published: 14 March 2014 nice.org.uk/guidance/sc1 NICE 2018. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-ofrights).

More information

Medicine Management Policy

Medicine Management Policy INDEX Prescribing Page 2 Dispensing Page 3 Safe Administration Page 4 Problems & Errors Page 5 Self Administration Page 7 Safe Storage Page 8 Controlled Drugs Best Practice Procedure Page 9 Controlled

More information

CLINICAL PROTOCOL FOR COMMUNITY PODIATRY PATIENTS WITH TYPE II DIABETES

CLINICAL PROTOCOL FOR COMMUNITY PODIATRY PATIENTS WITH TYPE II DIABETES CLINICAL PROTOCOL FOR COMMUNITY PODIATRY PATIENTS WITH TYPE II DIABETES RATIONALE Access to Community Podiatry services and treatment intervals for Diabetic patients, will generally be determined by the

More information

Document Details. Patient Group Direction

Document Details. Patient Group Direction Document Details Title Patient Group Direction (PGD) CO-CODAMOL 30/500 TABLETS FOR MINOR INJURIES UNITS Trust Ref No 1956-35206 Local Ref (optional) Main points the document treatment of moderate pain

More information

interrai New Zealand National Standards

interrai New Zealand National Standards interrai New Zealand National Standards (Home Care) Published September 2017 Contents New Zealand interrai National Standards... 2 General Standards... 3 Standards for assessment notes... 3 Standards for

More information

Ensuring our safeguarding arrangements act to help and protect adults PRACTICE GUIDANCE FOR REPORTING MEDICATION INCIDENTS INTO SAFEGUARDING

Ensuring our safeguarding arrangements act to help and protect adults PRACTICE GUIDANCE FOR REPORTING MEDICATION INCIDENTS INTO SAFEGUARDING Ensuring our safeguarding arrangements act to help and protect adults PRACTICE GUIDANCE FOR REPORTING MEDICATION INCIDENTS INTO SAFEGUARDING Contents Page 1.0 Purpose 2 2.0 Definition of medication error

More information

NURSING HOMES OPERATION REGULATION

NURSING HOMES OPERATION REGULATION Province of Alberta NURSING HOMES ACT NURSING HOMES OPERATION REGULATION Alberta Regulation 258/1985 With amendments up to and including Alberta Regulation 7/2017 Office Consolidation Published by Alberta

More information

Leprosy Elimination Monitoring in India

Leprosy Elimination Monitoring in India Leprosy Elimination Monitoring in India 2004 in collaboration with ILEP International Federation of Anti-Leprosy Associations Table of Contents Page No. Foreword.. iii Preface... iv Acknowledgement. v

More information

C. Physician s orders for medication, treatment, care and diet shall be reviewed and reordered no less frequently than every two (2) months.

C. Physician s orders for medication, treatment, care and diet shall be reviewed and reordered no less frequently than every two (2) months. SECTION 1300 - MEDICATION MANAGEMENT 1301. General A. Medications, including controlled substances, medical supplies, and those items necessary for the rendering of first aid shall be properly managed

More information

MEDICINES CONTROL COUNCIL

MEDICINES CONTROL COUNCIL MEDICINES CONTROL COUNCIL SECTION 21 APPLICATION FORM Only to be used for orthodox/allopathic medicines for human use. 1. Fax completed form (i.e. pages 1-10), proof of payment of application fee (if applicable)

More information

W e l c o m e t o B i l l e r i c a C h i r o p r a c t i c

W e l c o m e t o B i l l e r i c a C h i r o p r a c t i c W e l c o m e t o B i l l e r i c a C h i r o p r a c t i c N E W P A T I E N T I N T A K E F O R M Print Name Today s Date Address City State Zip Email Address Date of Birth Male Female Social Security

More information

Patient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM PEGYLATED LIPOSOMAL DOXORUBICIN (CAELYX)

Patient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM PEGYLATED LIPOSOMAL DOXORUBICIN (CAELYX) Patient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM PEGYLATED LIPOSOMAL DOXORUBICIN (CAELYX) Patient s surname/family name Patient s first names Date of birth Hospital

More information

St John the Evangelist RCP School

St John the Evangelist RCP School St John the Evangelist RCP School Children with Medical Conditions Policy Including the Administering of Medicines and First Aid Status Current Approval Curriculum Committee Maintenance Resources Responsibility

More information

HOW PROCESS MEASURES ARE CALCULATED

HOW PROCESS MEASURES ARE CALCULATED HOW PROCESS MEASURES ARE CALCULATED 1) Timely initiation in care (check at SOC and ROC) (5-star) Percentage of home health episodes of care in which the start or resumption of care date was either on the

More information

New Patient Registration Form NJR_NP_F100

New Patient Registration Form NJR_NP_F100 New Patient Registration Form NJR_NP_F100 Patient Last Name First Name Middle Name Maiden Name Address (Street or Box) City State Zip Code Home Phone Number Cell Phone Number Work Phone Number E-Mail Patient

More information

PHYSICIAN S RECOMMENDATION FOR PEDIATRIC CARE INSTRUCTIONS FOR COMPLETING THE PEDIATRIC CARE FORM DMA-6(A)

PHYSICIAN S RECOMMENDATION FOR PEDIATRIC CARE INSTRUCTIONS FOR COMPLETING THE PEDIATRIC CARE FORM DMA-6(A) PHYSICIAN S RECOMMENDATION FOR PEDIATRIC CARE INSTRUCTIONS FOR COMPLETING THE PEDIATRIC CARE FORM DMA-6(A) This section provides detailed instructions for completion of the Form DMA-6 (A). Before payment

More information

Persons affected by leprosy homes No. of persons affected by leprosy living in these homes Not Applicable

Persons affected by leprosy homes No. of persons affected by leprosy living in these homes Not Applicable DISTRICT PROFILE HARDOI (2008) Introduction is situated in the central part of Uttar Pradesh (UP). Geographically, it is the largest district of Uttar Pradesh. Agriculture is the main source of income

More information

Persons Affected with Leprosy Homes No. of PAL living in these homes

Persons Affected with Leprosy Homes No. of PAL living in these homes DISTRICT PROFILE - KANPUR NAGAR (2008) Introduction was first carved out of erstwhile Kanpur in 1977. It was reunited with Kanpur Dehat in 1979, to separate again in 1981. is a commercial capital of Uttar

More information

THE BOARD OF THE EURASIAN ECONOMIC COMMISSION RESOLUTION. dated December 22, 2015 N 174

THE BOARD OF THE EURASIAN ECONOMIC COMMISSION RESOLUTION. dated December 22, 2015 N 174 THE BOARD OF THE EURASIAN ECONOMIC COMMISSION RESOLUTION Dated December 22, 2015, N 174 ON APPROVAL OF REGULATIONS OF MEDICAL DEVICE SAFETY, QUALITY AND EFFECTIVENESS MONITORING In accordance with paragraph

More information

Hostel for SC/ST Students- HFS

Hostel for SC/ST Students- HFS All India Council for Technical Education (Under Ministry of HRD, GOI) AICTE Quality Improvement Schemes - AQIS User Manual for Scheme Hostel for SC/ST Students- HFS Table of Contents Icons for Buttons...

More information

NSS Units under Gauhati University NSS Cell are requested to send nominations for Awards for the categories mentioned below:

NSS Units under Gauhati University NSS Cell are requested to send nominations for Awards for the categories mentioned below: NSS Units under Gauhati University NSS Cell are requested to send nominations for Awards for the categories mentioned below: i) NSS Units and their Programme Officers ii) NSS Volunteers. Nature of Awards:

More information

SWEET HOME SCHOOL DISTRICT FAMILY AND MEDICAL LEAVE HANDBOOK

SWEET HOME SCHOOL DISTRICT FAMILY AND MEDICAL LEAVE HANDBOOK SWEET HOME SCHOOL DISTRICT FAMILY AND MEDICAL LEAVE HANDBOOK STEPS TO APPLY FOR OREGON FAMILY LEAVE &/OR FEDERAL MEDICAL LEAVE 1. Review handbook 2. Fill out a District Leave Request (attached) 3. Fill

More information

Patient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM PAZOPANIB. Patient s first names.

Patient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM PAZOPANIB. Patient s first names. Patient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM PAZOPANIB Patient s surname/family name Patient s first names Date of birth Hospital Name: Guy s Hospital St. Thomas

More information

Colorectal Surgery Enhanced Recovery Programme Preoperative Information Useful information Care

Colorectal Surgery Enhanced Recovery Programme Preoperative Information Useful information Care Colorectal Surgery Enhanced Recovery Programme Preoperative Information Useful information Name:... Consultant:... Date of Surgery:... Opera on:... WPR40870 April 2014 Review date by: March 2016 Explaining

More information

PROFORMA FOR SUBMISSION OF PROJECTS UNDER BIOTECHNOLOGY- BASED PROGRAMMES FOR RURAL DEVELOPMENT

PROFORMA FOR SUBMISSION OF PROJECTS UNDER BIOTECHNOLOGY- BASED PROGRAMMES FOR RURAL DEVELOPMENT PROFORMA II PROFORMA FOR SUBMISSION OF PROJECTS UNDER BIOTECHNOLOGY- BASED PROGRAMMES FOR RURAL DEVELOPMENT Guidelines for Formulation of R&D Proposals for Consideration under Biotechnology-Based programmes

More information

Patient Group Direction For the supply of Fusidic Acid 2% Cream

Patient Group Direction For the supply of Fusidic Acid 2% Cream Patient Group Direction For the supply of Fusidic Acid 2% Cream This Patient Group Direction (PGD) is a specific written instruction for the supply of Fusidic Acid 2% Cream to groups of patients who may

More information

Language, Literacy and Numeracy Core Skills Survey - (Community Services)

Language, Literacy and Numeracy Core Skills Survey - (Community Services) Language, Literacy and Numeracy Core Skills Survey - (Community Services) Introduction Thank you for choosing to embark on your learning journey with Australian Nursing and Training Services (ANTS) and

More information

Government of Andhra Pradesh Commissioner of Health & Family Welfare Recruitment Notification

Government of Andhra Pradesh Commissioner of Health & Family Welfare Recruitment Notification Government of Andhra Pradesh Commissioner of Health & Family Welfare Recruitment Notification 1. ASHA Programme Manager Requirement post 1 Qualification: MBBS / AYUSH / Nursing Graduate with Post Graduate

More information

User manual for Renewal Validity

User manual for Renewal Validity User manual for Renewal Validity 2017-18 If you have any old user id and password for updating of online faculty data, online new proposal and online enhancement will not work for this purpose. You have

More information

Supporting Children at School with Medical Conditions

Supporting Children at School with Medical Conditions Introduction Children and young people with medical conditions are entitled to a full education and have the same rights of admission to school as other children. This means that no child with a medical

More information

First Aid and Medicines Procedure

First Aid and Medicines Procedure First Aid and Medicines Procedure April 2017 First Aid 12.1 First aid provision for the academy will be adequate to cope with all foreseeable incidents. The level of first aid cover required will be determined

More information

PROFORMA FOR SUBMISSION OF PROJECTS UNDER BIOTECHNOLOGY- BASED PROGRAMMES FOR RURAL DEVELOPMENT

PROFORMA FOR SUBMISSION OF PROJECTS UNDER BIOTECHNOLOGY- BASED PROGRAMMES FOR RURAL DEVELOPMENT PROFORMA II PROFORMA FOR SUBMISSION OF PROJECTS UNDER BIOTECHNOLOGY- BASED PROGRAMMES FOR RURAL DEVELOPMENT Guidelines for Formulation of R&D Proposals for Consideration under Biotechnology-Based programmes

More information

Template (to be adapted by care home) Medication to be administered on a PRN (when required) basis in a care home environment

Template (to be adapted by care home) Medication to be administered on a PRN (when required) basis in a care home environment Template (to be adapted by care home) Medication to be administered on a PRN (when required) basis in a care home environment The PRN Purpose & Outcome Protocol (PRN POP) Background The term PRN (from

More information

SOFTWARE USER GUIDE PRIMARYCLINIC PRACTICE (PRACNET) Commercial-in-Confidence

SOFTWARE USER GUIDE PRIMARYCLINIC PRACTICE (PRACNET) Commercial-in-Confidence 2017 Commercial-in-Confidence SOFTWARE USER GUIDE PRIMARYCLINIC PRACTICE (PRACNET) Global Health Limited Level 2, 607 Bourke Street Melbourne VIC Australia 3000 T: +61 3 9675 0600 F: +61 39675 0699 www.primaryclinic.com.au

More information

Standard Operating Procedure for When required (PRN) medicines in care homes

Standard Operating Procedure for When required (PRN) medicines in care homes Standard Operating Procedure for When required (PRN) medicines in care homes Introduction All health and social care organisations are responsible for ensuring the safe management of all medicines. This

More information

Recognizing and Reporting Acute Change of Condition

Recognizing and Reporting Acute Change of Condition Recognizing and Reporting Acute Change of Condition Welcome to the Elizabeth McGowan Training Institute Cell Phones and Pagers Please turn your cell phones off or turn the ringer down during the session.

More information

Standard operating procedures for the conduct of outreach training and supportive supervision

Standard operating procedures for the conduct of outreach training and supportive supervision The MalariaCare Toolkit Tools for maintaining high-quality malaria case management services Standard operating procedures for the conduct of outreach training and supportive supervision Download all the

More information

SRIMATHI SUNDARAVALLI MEMORIAL RESIDENCY CHENNAI SUBHASHRAYA - AN IDEAL HOME FOR SENIOR CITIZENS Application Form for Admission

SRIMATHI SUNDARAVALLI MEMORIAL RESIDENCY CHENNAI SUBHASHRAYA - AN IDEAL HOME FOR SENIOR CITIZENS Application Form for Admission SRI SRIMATHI SUNDARAVALLI MEMORIAL RESIDENCY CHENNAI 600 063 SUBHASHRAYA - AN IDEAL HOME FOR SENIOR CITIZENS Application Form for Admission 1. Name (of the person to be :... admitted) in BLOCK letters

More information

Transnational Skill Standards Pharmacy Assistant

Transnational Skill Standards Pharmacy Assistant Transnational Skill Standards Pharmacy Assistant REFERENCE ID: HSS/ Q 5401 Mapping for Pharmacy Assistant (HSS/ Q 5401) with UK SVQ level 2 Qualification Certificate in Pharmacy Service Skills Link to

More information

2012 TB Laboratory Specimen Referral, Reporting & Transportation for diagnosis and management of MDR TB (January to June 2012)

2012 TB Laboratory Specimen Referral, Reporting & Transportation for diagnosis and management of MDR TB (January to June 2012) Questionnaire Serial No: 2012 TB Laboratory Specimen Referral, Reporting & Transportation for diagnosis and management of MDR TB (January to June 2012) Referring Facility Questionnaire Form 1 SECTION A:

More information

12/17/2015 F 0000 F 0314 F 0314 SS=G PRINTED: 9/12/2016 DEPARTMENT OF HEALTH AND HUMAN SERVICES HEALTH CARE FINANCING ADMINISTRATION SQC111

12/17/2015 F 0000 F 0314 F 0314 SS=G PRINTED: 9/12/2016 DEPARTMENT OF HEALTH AND HUMAN SERVICES HEALTH CARE FINANCING ADMINISTRATION SQC111 1.00 DEPARTMENT O HEALTH AND HUMAN SERVICES (XI) PROVER/SUPPLIER/CLIA ENTIICATION NUMBER: (X3) SURVEY D: NAME O PROVER OR SUPPLIER: (X4) PROVER'S PLAN O CORRECTION (EACH 0000 INITIAL COMMENT 0.00 0000

More information

Dow University of Health Sciences Karachi Department of Postgraduate Studies Baba-e-Urdu Road Karachi PAKISTAN

Dow University of Health Sciences Karachi Department of Postgraduate Studies Baba-e-Urdu Road Karachi PAKISTAN Dow University of Health Sciences Karachi Department of Postgraduate Studies Baba-e-Urdu Road Karachi PAKISTAN http://www.duhs.edu.pk (TRAINING NAME) ADMISSION FORM Application # (AP No) PHOTOGRAPH Specialty

More information

PATIENT GROUP DIRECTION (PGD) FOR

PATIENT GROUP DIRECTION (PGD) FOR Antibiotic Oral (tablet/capsule/suspension) PATIENT GROUP DIRECTION (PGD) FOR YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT Caution: This

More information

Please read the following carefully before completing this application

Please read the following carefully before completing this application 1 St Augustine College of South Africa Bursary Application Form 2019 Please read the following carefully before completing this application You may apply if: You have applied for admission for a degree

More information

INDEPENDENT NON-MEDICAL PRESCRIBING (NMPs) POLICY. Suffolk GP Federation Board

INDEPENDENT NON-MEDICAL PRESCRIBING (NMPs) POLICY. Suffolk GP Federation Board INDEPENDENT NON-MEDICAL PRESCRIBING (NMPs) POLICY Version: 1.0 Policy owner: Ratified by: Clinical Governance Lead Chief Executive Date approved: 28 th November 2014 Approved by: Suffolk GP Federation

More information

MINNESOTA. Downloaded January 2011

MINNESOTA. Downloaded January 2011 MINNESOTA Downloaded January 2011 4658.1300 MEDICATIONS AND PHARMACY SERVICES; DEFINITIONS. Subpart 1. Controlled substances. "Controlled substances" has the meaning given in Minnesota Statutes, section

More information

Inspection Protocol Skin and Wound Care. Definition / Description. Use. Resident-related Triggered

Inspection Protocol Skin and Wound Care. Definition / Description. Use. Resident-related Triggered Resident-related Triggered Home Name: Inspection Number: (hard copy use only) Date: Inspector ID: Definition / Description Altered skin integrity: The potential or actual disruption of epidermal or dermal

More information

Certification of Health Care Provider for Medical Leave (Family and Medical Leave Act of 1993 and all related state leave laws)

Certification of Health Care Provider for Medical Leave (Family and Medical Leave Act of 1993 and all related state leave laws) Certification of Health Care Provider for Medical Leave (Family and Medical Leave Act of 1993 and all related state leave laws) Note: Here and elsewhere on this form, the information sought relates only

More information

Medical Needs Policy. Policy Date: March 2017

Medical Needs Policy. Policy Date: March 2017 Medical Needs Policy Policy Date: March 2017 Renewal Date: March 2017 Equality Statement This policy takes into account the provisions of the Equality Act 2010 and advances equal opportunities for all.

More information

MONITORING AND EVALUATION PLAN

MONITORING AND EVALUATION PLAN GHANA HEALTH SERVICE MONITORING AND EVALUATION PLAN National tb control programme Monitoring and evaluation plan for NTP INTRODUCTION The Health System Structure in Ghana The Health Service is organized

More information